Yesterday Bayer announced it is joining the U.S. Government?s fight against COVID-19 with a donation of 3 million tablets of the drug Resochin (chloroquine phosphate).
Resochin, a product discovered by Bayer in 1934 and indicated for prevention and treatment of malaria, also appears to have broad spectrum antiviral properties and effects on the body?s immune response. New data from initial preclinical and evolving clinical research conducted in China, while limited, shows potential for the use of Resochin in treating patients with COVID-19 infection.
Bayer in recent days has been in talks with the White House, HHS, CDC, and the FDA, offering any assistance we can provide with a focus on donating Resochin to help in the government?s efforts to combat the virus. Currently not approved for use in the United States, Bayer is working with appropriate agencies on an Emergency Use Authorization for the drug?s use in the U.S.
Bayer thanks the Trump administration for moving quickly to enable this donation and will continue to work closely with the administration to support its efforts in the fight against COVID-19.? Continue reading